Search Results - "AVRIL, Norbert"
-
1
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Published in Clinical cancer research (15-09-2011)“…We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in ovarian cancer via abrogation of a tumor-promoting cytokine network. We…”
Get full text
Journal Article -
2
Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study
Published in Translational oncology (01-04-2016)“…Abstract Studying early response to cancer treatment is significant for patient treatment stratification and follow-up. Although recent advances in positron…”
Get full text
Journal Article -
3
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial
Published in JAMA oncology (01-01-2017)“…Preclinical studies show that arginine deprivation is synthetically lethal in argininosuccinate synthetase 1 (ASS1)-negative cancers, including mesothelioma…”
Get more information
Journal Article -
4
Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F]Fluorodeoxyglucose
Published in Journal of clinical oncology (01-02-2009)“…To evaluate positron emission tomography (PET) using [(18)F]fluorodeoxyglucose (FDG) for prediction of histopathologic response early during primary systemic…”
Get full text
Journal Article -
5
Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Published in Clinical cancer research (15-09-2011)“…To test the hypothesis that sequential (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is a correlative marker in…”
Get full text
Journal Article -
6
Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging
Published in Cancer research (Chicago, Ill.) (01-02-2014)“…Targeted therapies have yet to have significant impact on the survival of patients with bladder cancer. In this study, we focused on the urea cycle enzyme…”
Get full text
Journal Article -
7
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy
Published in European journal of nuclear medicine and molecular imaging (01-04-2019)“…Purpose The purpose of this study was to retrospectively review the role of post-treatment (post-tx) FDG-PET/CT scans in patients receiving postoperative…”
Get full text
Journal Article -
8
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
Published in Journal of clinical oncology (20-10-2005)“…The aim of this study was to evaluate sequential F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) to predict patient outcome after the first and…”
Get full text
Journal Article -
9
Monitoring response to treatment in patients utilizing PET
Published in The Radiologic clinics of North America (01-01-2005)“…Establishing new surrogate end points for monitoring response to treatment is needed for current therapy modalities and for new therapeutic strategies…”
Get more information
Journal Article -
10
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
Published in Journal of clinical oncology (15-06-2001)“…Preoperative chemotherapy in patients with gastroesophageal cancer is hampered by the lack of reliable predictors of tumor response. This study evaluates…”
Get full text
Journal Article -
11
Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test―Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
Published in Clinical cancer research (15-05-2014)“…Repeatability of baseline FDG-PET/CT measurements has not been tested in ovarian cancer. This dual-center, prospective study assessed variation in tumor…”
Get full text
Journal Article -
12
The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
Published in Current issues in molecular biology (30-04-2022)“…Gut microbiome balance plays a key role in human health and maintains gut barrier integrity. Dysbiosis, referring to impaired gut microbiome, is linked to a…”
Get full text
Journal Article -
13
Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring
Published in European journal of nuclear medicine and molecular imaging (01-08-2010)“…Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to…”
Get full text
Journal Article -
14
18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
Published in The Journal of nuclear medicine (1978) (01-02-2016)“…Changes in tumor metabolic activity have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the neoadjuvant setting…”
Get full text
Journal Article -
15
Altered glutamine metabolism in platinum resistant ovarian cancer
Published in Oncotarget (05-07-2016)Get full text
Journal Article -
16
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT
Published in European journal of endocrinology (01-06-2010)“…ObjectiveThe aim of the study was to assess the diagnostic performance of co-registered single photon emission computed tomography (SPECT)/computed tomography…”
Get full text
Journal Article -
17
Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer
Published in Human pathology (01-06-2007)“…Summary To date, no histopathologic criteria have been established to describe treatment response after neoadjuvant chemotherapy in ovarian cancer. The aim of…”
Get full text
Journal Article -
18
Imaging of Tumor-Associated Vascular Prostate-Specific Membrane Antigen in Woodchuck Model of Hepatocellular Carcinoma
Published in Gastro hep advances (2022)“…Radiolabeled short peptide ligands targeting prostate-specific membrane antigen (PSMA) were developed initially for imaging and treatment of prostate cancers…”
Get full text
Journal Article -
19
Neoadjuvant therapy of esophageal squamous cell carcinoma : Response evaluation by positron emission tomography
Published in Annals of surgery (01-03-2001)“…To evaluate the use of positron emission tomography using [(18)F]-fluorodeoxyglucose (FDG-PET) to assess the response to neoadjuvant radiotherapy and…”
Get full text
Journal Article -
20
The clinical advances of fluorine-2-D-deoxyglucose - positron emission tomography/computed tomography in urological cancers
Published in International journal of urology (01-06-2010)“…Fluorine‐18 labeled fluorine‐2‐D‐deoxyglucose (FDG) is the most frequently used positron emission tomography (PET) probe but it has certain limitations when…”
Get full text
Journal Article